Skip to main content
Top
Published in: PharmacoEconomics 10/2003

01-07-2003 | Original Research Article

Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling

Authors: Dr Susan J. Taylor, Carol L. Armour

Published in: PharmacoEconomics | Issue 10/2003

Login to get access

Abstract

Objective: To assess consumer preference for two methods of induction of labour using stated preference discrete choice modelling. The methods of induction were artificial rupture of the membranes (ARM) plus oxytocin and dinoprostone (prostaglandin E2) vaginal gel, followed by oxytocin if necessary.
Methods: Consumer preference was measured in terms of willingness to pay for each of the attributes. These attributes were the method of administration, place of care, length of time from induction to delivery, need for epidural anaesthetic, type of delivery and cost. Levels were assigned to each of the attributes. Pregnant women attending a public hospital antenatal clinic were asked to read a description of the two methods and then to choose between them in 18 different scenarios in which the levels of the attributes were varied.
Results: Women were willing to pay 11 Australian dollars ($A) for a 1% reduction in the chance of needing oxytocin as well as the gel and $A55 for every 1 hour reduction in the length of time from induction to delivery. For a 1% reduction in the chance of needing an epidural anaesthetic or Caesarean section, women expressed a willingness to pay of $A20 and $A90, respectively. All estimates were obtained in 1998 and expressed in Australian dollars ($A1 = $US0.63).
Conclusion: Women valued the less invasive method of administration of the gel and the associated greater freedom of movement during labour. However, they valued the shorter time from induction to delivery associated with ARM plus oxytocin more highly. A policy which allows women access to the gel for up to two doses would accommodate this consumer preference.
Literature
2.
go back to reference Johannesson M, Jonsson B. Economic evaluation in health care: is there a role for cost benefit analysis? Health Policy 1991; 17: 1–23PubMedCrossRef Johannesson M, Jonsson B. Economic evaluation in health care: is there a role for cost benefit analysis? Health Policy 1991; 17: 1–23PubMedCrossRef
3.
go back to reference Donaldson C, Shackley P, Abdalla M. Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited. Health Econ 1997; 6: 145–59PubMedCrossRef Donaldson C, Shackley P, Abdalla M. Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited. Health Econ 1997; 6: 145–59PubMedCrossRef
4.
go back to reference Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol Assess Health Care 1999; 15: 443–57PubMed Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol Assess Health Care 1999; 15: 443–57PubMed
5.
go back to reference O’Brien BJ, Novosel S, Torrance G, et al. Assessing the economic value of a new antidepressant-a willingness to pay approach. Pharmacoeconomics 1995; 8: 34–45PubMedCrossRef O’Brien BJ, Novosel S, Torrance G, et al. Assessing the economic value of a new antidepressant-a willingness to pay approach. Pharmacoeconomics 1995; 8: 34–45PubMedCrossRef
6.
go back to reference O’Brien BJ, Goeree R, Gafni A, et al. Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care. Med Care 1998; 36: 370–84PubMedCrossRef O’Brien BJ, Goeree R, Gafni A, et al. Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care. Med Care 1998; 36: 370–84PubMedCrossRef
7.
8.
go back to reference Davey P, Grainger D, MacMillan J, et al. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach. Pharmacoeconomics 1998; 13: 347–58PubMedCrossRef Davey P, Grainger D, MacMillan J, et al. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach. Pharmacoeconomics 1998; 13: 347–58PubMedCrossRef
9.
go back to reference Taylor SJ, Armour CL. Measurement of consumer preference for treatments to induce labour: a willingness to pay approach. Health Expect 2000; 3: 203–16PubMedCrossRef Taylor SJ, Armour CL. Measurement of consumer preference for treatments to induce labour: a willingness to pay approach. Health Expect 2000; 3: 203–16PubMedCrossRef
10.
go back to reference Upjohn. Prostin E2 vaginal gel: as close to “natural” as labour induction can be. Sydney, Australia: Upjohn, 1991 Upjohn. Prostin E2 vaginal gel: as close to “natural” as labour induction can be. Sydney, Australia: Upjohn, 1991
11.
go back to reference Taylor SJ, Peat JK, Armour CL. An evaluation of Prostaglandin E2 vaginal gel use in practice. J Clin Pharm Ther 1999; 24: 303–10PubMedCrossRef Taylor SJ, Peat JK, Armour CL. An evaluation of Prostaglandin E2 vaginal gel use in practice. J Clin Pharm Ther 1999; 24: 303–10PubMedCrossRef
12.
go back to reference Hahn GJ, Shapiro SS. A catalogue and computer programme for the design and analysis of orthogonal symmetric and asymmetric fractional factorial experiments. Schenectady (NY): General Electric Research and Development Center, 1964 Hahn GJ, Shapiro SS. A catalogue and computer programme for the design and analysis of orthogonal symmetric and asymmetric fractional factorial experiments. Schenectady (NY): General Electric Research and Development Center, 1964
13.
go back to reference Hair JFJ, Anderson RE, Tatham RL, et al. Multivariate data analysis with readings. 4th ed. New Jersey: Prentice Hall, 1995 Hair JFJ, Anderson RE, Tatham RL, et al. Multivariate data analysis with readings. 4th ed. New Jersey: Prentice Hall, 1995
14.
go back to reference McFadden D. Conditional logit analysis of qualitative choice behaviour. Berkley (CA): University of California, 1973 McFadden D. Conditional logit analysis of qualitative choice behaviour. Berkley (CA): University of California, 1973
15.
go back to reference Greene WH. LIMDEP version 7, user’s manual. Plainview (NY): Econometric Software Inc, 1998 Greene WH. LIMDEP version 7, user’s manual. Plainview (NY): Econometric Software Inc, 1998
16.
go back to reference Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999; 48: 535–46PubMedCrossRef Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999; 48: 535–46PubMedCrossRef
17.
go back to reference Domencich TA, McFadden D. Urban travel demand: a behavioral analysis. Amsterdam: North-Holland Publishing Company, 1975 Domencich TA, McFadden D. Urban travel demand: a behavioral analysis. Amsterdam: North-Holland Publishing Company, 1975
18.
go back to reference Scott A. Giving things up to have more of others: the implications of limited suitability for eliciting preferences in health and health care [discussion paper 01/98]. Aberdeen: Health Economics Research Unit, University of Aberdeen, 1998 Scott A. Giving things up to have more of others: the implications of limited suitability for eliciting preferences in health and health care [discussion paper 01/98]. Aberdeen: Health Economics Research Unit, University of Aberdeen, 1998
19.
go back to reference Ryan M, Hughes J. Using conjoint analysis to assess women’s preferences for miscarriage management. Health Econ 1997; 6: 261–73PubMedCrossRef Ryan M, Hughes J. Using conjoint analysis to assess women’s preferences for miscarriage management. Health Econ 1997; 6: 261–73PubMedCrossRef
20.
go back to reference Vick S, Scott A. Agency in health care: examining patients’ preferences for attributes of the doctor-patient relationship. J Health Econ 1998; 17: 587–605PubMedCrossRef Vick S, Scott A. Agency in health care: examining patients’ preferences for attributes of the doctor-patient relationship. J Health Econ 1998; 17: 587–605PubMedCrossRef
21.
go back to reference Bryan S, Buxton M, Sheldon R, et al. Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences. Health Econ 1998; 7: 595–603PubMedCrossRef Bryan S, Buxton M, Sheldon R, et al. Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences. Health Econ 1998; 7: 595–603PubMedCrossRef
22.
go back to reference Chinburapa V, Larson LN. Predicting prescribing intention and assessing drug attribute importance using conjoint analysis. J Pharm Mark Manage 1988; 3: 3–18CrossRef Chinburapa V, Larson LN. Predicting prescribing intention and assessing drug attribute importance using conjoint analysis. J Pharm Mark Manage 1988; 3: 3–18CrossRef
23.
go back to reference Ratcliffe J, Buxton M. Patients’ preferences regarding the process and outcomes of life-saving technology. Int J Technol Assess Health Care 1999; 15: 340–51PubMed Ratcliffe J, Buxton M. Patients’ preferences regarding the process and outcomes of life-saving technology. Int J Technol Assess Health Care 1999; 15: 340–51PubMed
24.
go back to reference Propper C. The disutility of time spent on the United Kingdom’s National Health Service waiting lists. J Hum Resour 1995; 30: 677–700CrossRef Propper C. The disutility of time spent on the United Kingdom’s National Health Service waiting lists. J Hum Resour 1995; 30: 677–700CrossRef
25.
go back to reference McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in health care. Pharmacoeconomics 1999; 15 (4): 357–67PubMedCrossRef McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in health care. Pharmacoeconomics 1999; 15 (4): 357–67PubMedCrossRef
26.
go back to reference Dawes RM, Corrigan B. Linear models in decision making. Psychol Bull 1974; 81 (2): 95–106CrossRef Dawes RM, Corrigan B. Linear models in decision making. Psychol Bull 1974; 81 (2): 95–106CrossRef
27.
go back to reference Emery D, Barron F. Axiomatic and numerical conjoint measurement: an evaluation of diagnostic efficacy. Psychometrika 1979; 44: 195–210CrossRef Emery D, Barron F. Axiomatic and numerical conjoint measurement: an evaluation of diagnostic efficacy. Psychometrika 1979; 44: 195–210CrossRef
28.
go back to reference Cramer IS. The logit model: an introduction for economists. New York: Edward Arnold, 1991 Cramer IS. The logit model: an introduction for economists. New York: Edward Arnold, 1991
Metadata
Title
Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling
Authors
Dr Susan J. Taylor
Carol L. Armour
Publication date
01-07-2003
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 10/2003
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321100-00004

Other articles of this Issue 10/2003

PharmacoEconomics 10/2003 Go to the issue

Original Research Article

Lower Respiratory Tract Infections